Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphomaPaola Bonetti, Francesco Bertoni, Andrea Rinaldi et al.|Blood|2013Cited by 70
Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletionMichael Mian, Francesco Bertoni, Marta Scandurra et al.|Annals of Oncology|2011Cited by 22
Recurrent 11q24.3 Gain Contributes to the Pathogenesis of Diffuse Large B Cell Lymphoma (DLBCL) by Deregulating ETS1 and FLI1Paola Bonetti, Francesco Bertoni, Monica Testoni et al.|Blood|2011Cited by 0